Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 92Sarcoma 64Genitourinary 30Other hematologic neoplasm 22Gynecologic 16CNS 16Thoracic 11Other solid neoplasm 8Breast 6Gastrointestinal 5Head & Neck 3Dermatologic 3Plasma cell 1Classical hematology 1

Conditions

Thrombocytopenia 1

Interventions

Cyclophosphamide 79fludarabine phosphate 75Busulfan 53Whole-Body Irradiation 51Mycophenolic Acid 50Cyclosporine 47Peripheral Blood Stem Cell Transplantation 46fludarabine 42Antilymphocyte Serum 37Melphalan 36Tacrolimus 35Filgrastim 30Cord Blood Stem Cell Transplantation 27Radiotherapy 23Methotrexate 22Cytarabine 22Methylprednisolone 19Granulocyte Colony-Stimulating Factor 18apixaban 17Thiotepa 17Dalteparin 13thymoglobulin 12Rivaroxaban 12Alemtuzumab 12eltrombopag 11ferric carboxymaltose 10Surveys and Questionnaires 10Etoposide 10Epoetin Alfa 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ifosfamide × Classical hematology × Clear all
NCT00147225 2014-05-08

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

M.D. Anderson Cancer Center

Phase 1/2 Completed
55 enrolled 11 charts
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡